Prescription Drug Costs

Trump Reverses Drug Price Rule, Sparking Outrage

Donald Trump rescinded the Biden-Harris executive order aimed at lowering prescription drug costs, reversing efforts to increase affordability. This action aligns with Trump’s past proposals to cut spending on entitlement programs like Medicare and Medicaid, prioritizing the interests of Big Pharma over those of American citizens. His previous budgets included substantial cuts to these programs, contradicting his public statements. This reversal demonstrates a consistent pattern of favoring wealthy donors and corporations at the expense of social welfare.

Read More

Medicare’s $2,000 Drug Cap: Relief for Cancer Patients, But for How Long?

Beginning January 1st, Medicare’s Inflation Reduction Act establishes a $2,000 annual out-of-pocket maximum for prescription drugs, significantly impacting the more than 65 million Medicare enrollees. This cap, applying to all Part D drugs, offers substantial relief, particularly to cancer patients who often face exorbitant medication costs. Previously, Medicare recipients could spend $7,000 or more before catastrophic coverage began; this change eliminates that substantial financial burden for many. While some advocate for an even lower cap, the $2,000 limit is expected to provide considerable financial relief and reduce medical debt for millions.

Read More